Skip to content

Clinical trials

Central Nervous System Diseases trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Sweden Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20102
20121
20151
20171
20181
20192
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Novartis2
Novartis Pharmaceuticals2
Umeå University2
AC Immune SA1
Bial R&D Investments, S.A.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Renishaw1
Sumitomo Pharma Switzerland GmbH1
University College Cork1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases14
Brain Diseases10
Alzheimer Disease7
Nervous System Diseases6
Neurodegenerative Diseases6
Dementia5
Basal Ganglia Diseases3
Mental Disorders3
Movement Disorders3
Cognitive Dysfunction2

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.